Treatment of systolic hypertension and severe asymptomatic aortic regurgitation.
Handler
Joel
J
Kaiser Permanente, Anaheim, CA 92807, USA. joel.handler@kp.org
D000369:Aged, 80 and over; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001022:Aortic Valve Insufficiency / Q000188:drug therapy* / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013599:Systole / Q000187:drug effects
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D049993:Sodium Chloride Symporter Inhibitors